Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
956 DKK | +0.09% | -4.37% | -28.12% |
03-27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-28.12% | 4.89M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+1.51% | 22.78B | |
-10.81% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- ORPHA Stock
- News Orphazyme A/S
- Orphazyme to Halve Workforce to Cut Costs, to Delist from Nasdaq -- Stock Dives 40% After-Hours